China's Vcanbio Opens Boston Offices to Hunt for Cell and Immuno-Therapy Products

China's Vcanbio Cell & Gene Engineering Corporation, a Tianjin stem cell and cord banking company, has opened two subsidiary companies in the Boston area.  Vcanbio USA will be the company's North America investment arm, specializing in novel cell therapy and immunotherapy products. Vcanbio CTB will offer CRO-type translation services for novel therapies, which will operate through partnerships and co-development. More details.... Stock Symbol: (SHA: 600645) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.